申请人:Galderma Research & Development
公开号:US10202346B2
公开(公告)日:2019-02-12
The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I):
or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
描述了化合物在治疗皮肤疾病中的用途。特别是式(I)化合物的使用:
或其药学上可接受的盐、溶液或水合物之一用于制备治疗皮肤病的药物。